Symbiomix Therapeutics, LLC

Pharmaceutical company · Newark, New Jersey, United States

Symbiomix Therapeutics, LLC is a pharmaceutical company headquartered in Newark, New Jersey, United States. Its earliest recorded incorporation is in 2012. It has reported private securities offerings to the US SEC, most recently $6 million sold in a notice filed in 2016.

Profile compiled from public records. Is this your company? Request a correction or update

Symbiomix Therapeutics at a glance

Typepharmaceutical company

HeadquartersNewark, New Jersey, United States

Earliest incorporation on record2012

SEC CIK1612502

What does Symbiomix Therapeutics do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $6 million sold (2016).

Frequently asked questions about Symbiomix Therapeutics

Where is Symbiomix Therapeutics headquartered?

Symbiomix Therapeutics, LLC is headquartered in Newark, New Jersey, United States.

What does Symbiomix Therapeutics do?

Symbiomix Therapeutics, LLC is a pharmaceutical company.

When was Symbiomix Therapeutics founded?

The earliest incorporation on record for Symbiomix Therapeutics, LLC is in 2012, according to public company registers.

Similar companies

Protagonist Therapeutics, IncNewark, California, United States
Rain Oncology Inc.Newark, California, United States
Rafael Holdings, Inc.Newark, New Jersey, United States
InCarda Therapeutics, Inc.Newark, California, United States
CymaBay Therapeutics, Inc.Newark, California, United States
Inergetics IncNewark, New Jersey, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences